Asian Spectator

ACN Newswire Business

Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System

  • Written by ACN Newswire - Press Releases

Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System

Hamburg / Tokyo, Oct 9, 2020 - (ACN Newswire) - Olympus Corporation today announced the launch of ENDO-AID(1), a cutting-edge platform powered by artificial intelligence (AI) that includes the endoscopy application ENDO-AID CADe (computer-aided detection) for the colon. This new AI platform enables real-time display of automatically detected suspicious lesions and works in combination with Olympus' recently introduced EVIS X1, its most advanced endoscopy system to date.

Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System

ENDO-AID CADe: real-time computer-aided detection for endoscopy

Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System

ENDO-AID

Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System

ENDO-AID with EVIS X1

As a global leader in designing and delivering innovative solutions for medical and surgical procedures, Olympus aims to improve the health and quality of life of patients by providing advanced medical technologies. Its latest endoscopy system, EVIS X1, was developed to set new standards for image detection, characterization, staging, and treatment. With the newly introduced endoscopy CAD (computer-aided detection/diagnosis) platform ENDO-AID, Olympus is now enhancing the capabilities of EVIS X1 through AI technology, aiming to elevate the standard of endoscopy around the world - whether for applications to disorders of the esophagus, stomach, colon or other gastrointestinal organs.

ENDO-AID CADe: real-time computer-aided detection for endoscopy

ENDO-AID CADe is an application for computer-aided detection powered by AI which runs on ENDO-AID. It uses a complex algorithm via a neural network developed and trained by Olympus. With this new application, the system's sophisticated machine learning can alert the endoscopist in real time when a suspected colonic lesion (such as a polyp, malignant neoplasm or adenoma) appears on the screen.

ENDO-AID CADe was developed toward the following improvements:

- Improved observational performance in adenoma detection: By providing visual support, ENDO-AID CADe aims to improve the observational performance of the endoscopist's adenoma detection.- Support of the colonoscopy screening process: The system provides visual support during screening, allowing the endoscopist to focus on any abnormalities indicated by the software regardless of the experience level of the endoscopist.- Efficient endoscopy operation: Due to the simple and intuitive display of lesions, ENDO-AID CADe has the potential to make endoscopy easier and more efficient for the endoscopist by reducing the need for excessive eye movements.

A first step towards the future of endoscopic diagnosis and therapy

With ENDO-AID, the latest feature of the EVIS X1 endoscopy system, Olympus has created the basis and infrastructure for the installation of future applications supported by AI. "At Olympus we are committed to innovation and driving our research and development with passion," says Frank Drewalowski, Head of Endoscopic Solutions Division, Olympus Corporation. "Especially in AI, we recognize the power of elevating endoscopic imaging to uncharted levels. Considering ENDO-AID as a first step, we are planning additional AI-powered applications for image detection and characterization - not only for colonoscopy."

Prevention of colorectal cancer remains our focus

There is a positive impact of an increase in adenoma detection rate (ADR) on the prevention of colorectal cancer (CRC)(2). Supporting the identification of lesions, ENDO-AID CADe is designed to increase ADR(3). We are aiming to increase the quality of CRC screening and its preventive efficacy against CRC. The prevention of CRC is a core element of Olympus' endeavors in medical endoscopy and beyond."With the launch of ENDO-AID, we are not only providing endoscopists across the world with an additional innovative tool," says Takaharu Yamada, Vice President, GI Endoscopy Business Leader, Endoscopic Solutions Division. "We are also preparing for the future and following our vision of putting CRC in the history books."

Official launch at United European Gastroenterology Week (UEGW)

During the virtual UEGW from October 11 to 13, ENDO-AID will be presented to the public for the first time. ENDO-AID is initially and commercially being launched in Europe beginning in November, followed shortly afterwards by some Middle Eastern, African and Asian-Pacific countries. Japan, the Americas and China markets will follow at a later time after complying with laws and regulations in each region. EVIS X1 and ENDO-AID are manufactured by Olympus Medical Systems Corporation. The company and product names specified in this release are the trademarks or registered trademarks of Olympus.

(1) Product Name: Endoscopy CAD system(2) Corley, D.A.; Jensen, C.D.; Marks, A.R.; et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. N Engl J Med. 2014; 370: 1298-1306. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036494/. Accessed in October 2020(3) Compared to WLI (white light imaging) without CADe

About Olympus

Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries, as well as cameras and audio products. For more than 100 years, Olympus has focused on making people's lives healthier, safer, and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, ensuring public safety, and capturing images of the world.

Olympus Endoscopic Solutions uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with the world's first gastrocamera in 1950, Olympus' endoscopic portfolio has grown to include endoscopes, laparoscopes, and video imaging systems, as well as systems integration solutions and medical services.

For questions or additional information, please contact:Europe, Middle East and Africa Matthias Gengenbach +49 15142369420matthias.gengenbach@olympus-europa.com

Japan Yuka Horimoto+81 90 2490 1071yuka_horimoto@ot.olympus.co.jp

Asia Pacific Oliver Clarke+61 3 9271 5508oliver.clarke@olympus.com.au

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

CGTN: China Marks 70th Anniversary of War to Resist U.S. Aggre...

BEIJING, Oct. 23, 2020 /PRNewswire-AsiaNet/-- China on Friday held an event to commemorate the 70th anniversary of the Chinese People's Volunteers (CPV) army entering the Democratic People's...

Cappfinity appoints Lindsey Pollak as Brand Ambassador for gam...

NEW YORK, Oct. 23, 2020 /PRNewswire-AsiaNet/ -- HR Tech firm, Cappfinity, is working with Lindsey Pollak to bring the company's new Virtual Experience and Engagement platform to the early ca...

AXA supports Hong Kong Cancer Fund Dress Pink Day as Principal Sponsor

Over 1,000 staff dressed in pink to raise breast cancer awareness and fundraise for free cancer care service HONG KONG, CHINA - Media OutReach - 23 October 2020 -October ...

Galeries Lafayette signs an agreement to open a third store in...

PARIS and GUIYANG, China, Oct. 23, 2020 /PRNewswire-AsiaNet/ -- After opening two emblematic stores in Beijing and Shanghai, Galeries Lafayette continues to expand in China and announces the...

West China's Chongqing Yubei makes one feel at home and connec...

CHONGQING, China, Oct. 23, 2020 /Xinhua-AsiaNet/-- The Yubei District of west China's Chongqing Municipality is a place where one can feel like at home and connected with the outside world. ...

Lear Climate Change Strategy Aims for Net Zero Emissions by 2050

SOUTHFIELD, Mich., Oct. 23, 2020 /PRNewswire-AsiaNet/ -- Company targets 2030 to convert to 100% renewable energy and cut carbon emissions by 50%Lear Corporation (NYSE: LEA), a global automo...

Magazine

Australian startup CareApp receives funding injection to expand app

Australian based startup CareApp has recently raised over $500,000 in funding including $250,000 provided by the South Australian State Government to rapidly expand and scale up their smartphone...

Shaparency launches to enable businesses to go fully digital

New venture developed for post-Covid-19 corporate landscape London-based start-up Shaparency, which has been established in response to the business conditions resulting from Covid-19, announces ...

Specops Significant Cyber Attacks

The prevalence and severity of cyber attacks are increasing at an alarming rate every year. So much so, that statistics from Cybersecurity Ventures estimate that cybercrime will cost the global ...

Writers Wanted



News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion